Avoid common mistakes on your manuscript.
Correction to: Drugs & Therapy Perspectives (2020) https://doi.org/10.1007/s40267-020-00801-2
An Online First version of this article was made available online at https://link.springer.com/article/10.1007/s40267-020-00801-2 on 5 December 2020. An error was subsequently identified in the article, and the following correction should be noted.
Page 4, Table 2, 'Inhibitors of the CGRP pathway' section, ‘Eptinezumab' row: The cell entry in the 'Recommended dosage' column, which previously read:
“100 mg as IV infusion q1mo (may ↑ to 300 mg)”
should read:
“100 mg as IV infusion q3mo (may ↑ to 300 mg)”
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patel, N., Barnhart, R., Konkol, P. et al. Corrections to: Treatment of migraine: a review of disease burden and an update on the therapeutic landscape for pharmacists. Drugs Ther Perspect 37, 100 (2021). https://doi.org/10.1007/s40267-020-00810-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-020-00810-1